{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:42:40Z","timestamp":1791085360450,"version":"4.1.0"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,10,29]],"date-time":"2009-10-29T00:00:00Z","timestamp":1256774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,10,29]],"date-time":"2009-10-29T00:00:00Z","timestamp":1256774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1038\/leu.2009.223","type":"journal-article","created":{"date-parts":[[2009,10,29]],"date-time":"2009-10-29T10:44:34Z","timestamp":1256813074000},"page":"13-21","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Targeted therapy in T-cell malignancies: dysregulation of the cellular signaling pathways"],"prefix":"10.1038","volume":"24","author":[{"given":"W-L","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,10,29]]},"reference":[{"key":"BFleu2009223_CR1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc839","volume":"2","author":"I Vivanco","year":"2002","unstructured":"Vivanco I, Sawyers CL . The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer 2002; 2: 489\u2013501.","journal-title":"Nat Rev Cancer"},{"key":"BFleu2009223_CR2","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/leu.2008.26","volume":"22","author":"LS Steelman","year":"2008","unstructured":"Steelman LS, Abrams SL, Whelan J, Bertrand FE, Ludwig DE, Basecke J et al. Contributions of the Raf\/MEK\/ERK, PI3K\/PTEN\/Akt\/mTOR and Jak\/STAT pathways to leukemia. Leukemia 2008; 22: 686\u2013707.","journal-title":"Leukemia"},{"key":"BFleu2009223_CR3","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/leu.2008.27","volume":"22","author":"JA McCubrey","year":"2008","unstructured":"McCubrey JA, Steelman LS, Abrams SL, Bertrand FE, Ludwig DE, Basecke J et al. Targeting survival cascades induced by activation of Ras\/Raf\/MEK\/ERK, PI3K\/PTEN\/Akt\/mTOR and Jak\/STAT pathways for effective leukemia therapy. Leukemia 2008; 22: 708\u2013722.","journal-title":"Leukemia"},{"key":"BFleu2009223_CR4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s12026-008-8038-9","volume":"42","author":"VI Brown","year":"2008","unstructured":"Brown VI, Seif AE, Reid GS, Teachey DT, Grupp SA . Novel molecular and cellular therapeutic targets in acute lymphoblastic leukemia and lymphoproliferative disease. Immunol Res 2008; 42: 84\u2013105.","journal-title":"Immunol Res"},{"key":"BFleu2009223_CR5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.imlet.2007.12.008","volume":"116","author":"MM Juntilla","year":"2008","unstructured":"Juntilla MM, Koretzky GA . Critical roles of the PI3K\/Akt signaling pathway in T cell development. Immunol Lett 2008; 116: 104\u2013110.","journal-title":"Immunol Lett"},{"key":"BFleu2009223_CR6","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm1636","volume":"13","author":"T Palomero","year":"2007","unstructured":"Palomero T, Sulis ML, Cortina M, Real PJ, Barnes K, Ciofani M et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med 2007; 13: 1203\u20131210.","journal-title":"Nat Med"},{"key":"BFleu2009223_CR7","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1172\/JCI34616","volume":"118","author":"A Silva","year":"2008","unstructured":"Silva A, Yunes JA, Cardoso BA, Martins LR, Jotta PY, Abecasis M et al. PTEN posttranslational inactivation and hyperactivation of the PI3K\/Akt pathway sustain primary T cell leukemia viability. J Clin Invest 2008; 118: 3762\u20133774.","journal-title":"J Clin Invest"},{"key":"BFleu2009223_CR8","doi-asserted-by":"crossref","first-page":"6589","DOI":"10.1158\/0008-5472.CAN-05-3018","volume":"66","author":"F Vega","year":"2006","unstructured":"Vega F, Medeiros LJ, Leventaki V, Atwell C, Cho-Vega JH, Tian L et al. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Cancer Res 2006; 66: 6589\u20136597.","journal-title":"Cancer Res"},{"key":"BFleu2009223_CR9","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1074\/jbc.M806325200","volume":"284","author":"RI Fukuda","year":"2009","unstructured":"Fukuda RI, Tsuchiya K, Suzuki K, Itoh K, Fujita J, Utsunomiya A et al. Human T-cell leukemia virus type I Tax down-regulates the expression of phosphatidylinositol 3,4,5-trisphosphate inositol phosphatases via the NF-{kappa}B pathway. J Biol Chem 2009; 284: 2680\u20132689.","journal-title":"J Biol Chem"},{"key":"BFleu2009223_CR10","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.leukres.2006.08.001","volume":"31","author":"T Ikezoe","year":"2007","unstructured":"Ikezoe T, Nishioka C, Bandobashi K, Yang Y, Kuwayama Y, Adachi Y et al. Longitudinal inhibition of PI3K\/Akt\/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells. Leuk Res 2007; 31: 673\u2013682.","journal-title":"Leuk Res"},{"key":"BFleu2009223_CR11","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/path.2219","volume":"213","author":"YK Jeon","year":"2007","unstructured":"Jeon YK, Park CH, Kim KY, Li YC, Kim J, Kim YA et al. The heat-shock protein 90 inhibitor, geldanamycin, induces apoptotic cell death in Epstein-Barr virus-positive NK\/T-cell lymphoma by Akt down-regulation. J Pathol 2007; 213: 170\u2013179.","journal-title":"J Pathol"},{"key":"BFleu2009223_CR12","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1182\/blood-2005-08-3076","volume":"107","author":"AE Schade","year":"2006","unstructured":"Schade AE, Powers JJ, Wlodarski MW, Maciejewski JP . Phosphatidylinositol-3-phosphate kinase pathway activation protects leukemic large granular lymphocytes from undergoing homeostatic apoptosis. Blood 2006; 107: 4834\u20134840.","journal-title":"Blood"},{"key":"BFleu2009223_CR13","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1182\/blood-2007-06-095182","volume":"111","author":"M Marzec","year":"2008","unstructured":"Marzec M, Liu X, Kasprzycka M, Witkiewicz A, Raghunath PN, El-Salem M et al. IL-2- and IL-15-induced activation of the rapamycin-sensitive mTORC1 pathway in malignant CD4+ T lymphocytes. Blood 2008; 111: 2181\u20132189.","journal-title":"Blood"},{"key":"BFleu2009223_CR14","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1745-7254.2008.00767.x","volume":"29","author":"YM Zhao","year":"2008","unstructured":"Zhao YM, Zhou Q, Xu Y, Lai XY, Huang H . Antiproliferative effect of rapamycin on human T-cell leukemia cell line Jurkat by cell cycle arrest and telomerase inhibition. Acta Pharmacol Sin 2008; 29: 481\u2013488.","journal-title":"Acta Pharmacol Sin"},{"key":"BFleu2009223_CR15","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1182\/blood-2005-03-0929","volume":"106","author":"R Avellino","year":"2005","unstructured":"Avellino R, Romano S, Parasole R, Bisogni R, Lamberti A, Poggi V et al. Rapamycin stimulates apoptosis of childhood acute lymphoblastic leukemia cells. Blood 2005; 106: 1400\u20131406.","journal-title":"Blood"},{"key":"BFleu2009223_CR16","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.1038\/sj.onc.1210346","volume":"26","author":"M Marzec","year":"2007","unstructured":"Marzec M, Kasprzycka M, Liu X, El-Salem M, Halasa K, Raghunath PN et al. Oncogenic tyrosine kinase NPM\/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway. Oncogene 2007; 26: 5606\u20135614.","journal-title":"Oncogene"},{"key":"BFleu2009223_CR17","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ccr.2006.09.006","volume":"10","author":"G Wei","year":"2006","unstructured":"Wei G, Twomey D, Lamb J, Schlis K, Agarwal J, Stam RW et al. Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance. Cancer Cell 2006; 10: 331\u2013342.","journal-title":"Cancer Cell"},{"key":"BFleu2009223_CR18","doi-asserted-by":"crossref","first-page":"6436","DOI":"10.1038\/sj.onc.1209886","volume":"25","author":"JB Easton","year":"2006","unstructured":"Easton JB, Houghton PJ . mTOR and cancer therapy. Oncogene 2006; 25: 6436\u20136446.","journal-title":"Oncogene"},{"key":"BFleu2009223_CR19","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.coph.2008.08.004","volume":"8","author":"TA Yap","year":"2008","unstructured":"Yap TA, Garrett MD, Walton MI, Raynaud F, de Bono JS, Workman P . Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises. Curr Opin Pharmacol 2008; 8: 393\u2013412.","journal-title":"Curr Opin Pharmacol"},{"key":"BFleu2009223_CR20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ccr.2006.03.029","volume":"9","author":"QW Fan","year":"2006","unstructured":"Fan QW, Knight ZA, Goldenberg DD, Yu W, Mostov KE, Stokoe D et al. A dual PI3 kinase\/mTOR inhibitor reveals emergent efficacy in glioma. Cancer Cell 2006; 9: 341\u2013349.","journal-title":"Cancer Cell"},{"key":"BFleu2009223_CR21","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1158\/0008-5472.CAN-08-4884","volume":"69","author":"F Chiarini","year":"2009","unstructured":"Chiarini F, Fala F, Tazzari PL, Ricci F, Astolfi A, Pession A et al. Dual inhibition of class IA phosphatidylinositol 3-kinase and mammalian target of rapamycin as a new therapeutic option for T-cell acute lymphoblastic leukemia. Cancer Res 2009; 69: 3520\u20133528.","journal-title":"Cancer Res"},{"key":"BFleu2009223_CR22","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/leu.2008.79","volume":"22","author":"F Chiarini","year":"2008","unstructured":"Chiarini F, Del Sole M, Mongiorgi S, Gaboardi GC, Cappellini A, Mantovani I et al. The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism. Leukemia 2008; 22: 1106\u20131116.","journal-title":"Leukemia"},{"key":"BFleu2009223_CR23","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1158\/1535-7163.MCT-06-0076","volume":"5","author":"M Nyakern","year":"2006","unstructured":"Nyakern M, Cappellini A, Mantovani I, Martelli AM . Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated extrinsic cell death pathways. Mol Cancer Ther 2006; 5: 1559\u20131570.","journal-title":"Mol Cancer Ther"},{"key":"BFleu2009223_CR24","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1124\/mol.108.047639","volume":"74","author":"F Fala","year":"2008","unstructured":"Fala F, Blalock WL, Tazzari PL, Cappellini A, Chiarini F, Martinelli G et al. Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-ami ne (A443654) in T-cell acute lymphoblastic leukemia. Mol Pharmacol 2008; 74: 884\u2013895.","journal-title":"Mol Pharmacol"},{"key":"BFleu2009223_CR25","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/sj.jid.5700322","volume":"126","author":"C Querfeld","year":"2006","unstructured":"Querfeld C, Rizvi MA, Kuzel TM, Guitart J, Rademaker A, Sabharwal SS et al. The selective protein kinase C beta inhibitor enzastaurin induces apoptosis in cutaneous T-cell lymphoma cell lines through the AKT pathway. J Invest Dermatol 2006; 126: 1641\u20131647.","journal-title":"J Invest Dermatol"},{"key":"BFleu2009223_CR26","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.bcp.2007.08.001","volume":"74","author":"V Cecchinato","year":"2007","unstructured":"Cecchinato V, Chiaramonte R, Nizzardo M, Cristofaro B, Basile A, Sherbet GV et al. Resveratrol-induced apoptosis in human T-cell acute lymphoblastic leukaemia MOLT-4 cells. Biochem Pharmacol 2007; 74: 1568\u20131574.","journal-title":"Biochem Pharmacol"},{"key":"BFleu2009223_CR27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00280-004-0974-z","volume":"56","author":"SS Park","year":"2005","unstructured":"Park SS, Kim YN, Jeon YK, Kim YA, Kim JE, Kim H et al. Genistein-induced apoptosis via Akt signaling pathway in anaplastic large-cell lymphoma. Cancer Chemother Pharmacol 2005; 56: 271\u2013278.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BFleu2009223_CR28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10495-006-3392-3","volume":"11","author":"AR Hussain","year":"2006","unstructured":"Hussain AR, Al-Rasheed M, Manogaran PS, Al-Hussein KA, Platanias LC, Al Kuraya K et al. Curcumin induces apoptosis via inhibition of PI3\u2032-kinase\/AKT pathway in acute T-cell leukemias. Apoptosis 2006; 11: 245\u2013254.","journal-title":"Apoptosis"},{"key":"BFleu2009223_CR29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ni1045","volume":"5","author":"F Radtke","year":"2004","unstructured":"Radtke F, Wilson A, Mancini SJ, MacDonald HR . Notch regulation of lymphocyte development and function. Nat Immunol 2004; 5: 247\u2013253.","journal-title":"Nat Immunol"},{"key":"BFleu2009223_CR30","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.pathmechdis.3.121806.154300","volume":"3","author":"JC Aster","year":"2008","unstructured":"Aster JC, Pear WS, Blacklow SC . Notch signaling in leukemia. Annu Rev Pathol 2008; 3: 587\u2013613.","journal-title":"Annu Rev Pathol"},{"key":"BFleu2009223_CR31","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1084\/jem.20081922","volume":"206","author":"S Gonzalez-Garcia","year":"2009","unstructured":"Gonzalez-Garcia S, Garcia-Peydro M, Martin-Gayo E, Ballestar E, Esteller M, Bornstein R et al. CSL-MAML-dependent Notch1 signaling controls T lineage-specific IL-7R{alpha} gene expression in early human thymopoiesis and leukemia. J Exp Med 2009; 206: 779\u2013791.","journal-title":"J Exp Med"},{"key":"BFleu2009223_CR32","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0092-8674(91)90111-B","volume":"66","author":"LW Ellisen","year":"1991","unstructured":"Ellisen LW, Bird J, West DC, Soreng AL, Reynolds TC, Smith SD et al. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 1991; 66: 649\u2013661.","journal-title":"Cell"},{"key":"BFleu2009223_CR33","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1084\/jem.183.5.2283","volume":"183","author":"WS Pear","year":"1996","unstructured":"Pear WS, Aster JC, Scott ML, Hasserjian RP, Soffer B, Sklar J et al. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J Exp Med 1996; 183: 2283\u20132291.","journal-title":"J Exp Med"},{"key":"BFleu2009223_CR34","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1128\/MCB.23.2.655-664.2003","volume":"23","author":"AP Weng","year":"2003","unstructured":"Weng AP, Nam Y, Wolfe MS, Pear WS, Griffin JD, Blacklow SC et al. Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of notch signaling. Mol Cell Biol 2003; 23: 655\u2013664.","journal-title":"Mol Cell Biol"},{"key":"BFleu2009223_CR35","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","volume":"306","author":"AP Weng","year":"2004","unstructured":"Weng AP, Ferrando AA, Lee W, Morris 4th JP, Silverman LB, Sanchez-Irizarry C et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004; 306: 269\u2013271.","journal-title":"Science"},{"key":"BFleu2009223_CR36","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/carcin\/bgh124","volume":"25","author":"P Lopez-Nieva","year":"2004","unstructured":"Lopez-Nieva P, Santos J, Fernandez-Piqueras J . Defective expression of Notch1 and Notch2 in connection to alterations of c-Myc and Ikaros in gamma-radiation-induced mouse thymic lymphomas. Carcinogenesis 2004; 25: 1299\u20131304.","journal-title":"Carcinogenesis"},{"key":"BFleu2009223_CR37","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1182\/blood.V99.9.3398","volume":"99","author":"F Jundt","year":"2002","unstructured":"Jundt F, Anagnostopoulos I, Forster R, Mathas S, Stein H, Dorken B . Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. Blood 2002; 99: 3398\u20133403.","journal-title":"Blood"},{"key":"BFleu2009223_CR38","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1365-2133.2007.08427.x","volume":"158","author":"MR Kamstrup","year":"2008","unstructured":"Kamstrup MR, Ralfkiaer E, Skovgaard GL, Gniadecki R . Potential involvement of Notch1 signalling in the pathogenesis of primary cutaneous CD30-positive lymphoproliferative disorders. Br J Dermatol 2008; 158: 747\u2013753.","journal-title":"Br J Dermatol"},{"key":"BFleu2009223_CR39","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1093\/emboj\/19.13.3337","volume":"19","author":"D Bellavia","year":"2000","unstructured":"Bellavia D, Campese AF, Alesse E, Vacca A, Felli MP, Balestri A et al. Constitutive activation of NF-kappaB and T-cell leukemia\/lymphoma in Notch3 transgenic mice. EMBO J 2000; 19: 3337\u20133348.","journal-title":"EMBO J"},{"key":"BFleu2009223_CR40","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1158\/0008-5472.CAN-08-2791","volume":"69","author":"S Indraccolo","year":"2009","unstructured":"Indraccolo S, Minuzzo S, Masiero M, Pusceddu I, Persano L, Moserle L et al. Cross-talk between tumor and endothelial cells involving the Notch3-Dll4 interaction marks escape from tumor dormancy. Cancer Res 2009; 69: 1314\u20131323.","journal-title":"Cancer Res"},{"key":"BFleu2009223_CR41","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1182\/blood-2004-01-0204","volume":"104","author":"SM Vercauteren","year":"2004","unstructured":"Vercauteren SM, Sutherland HJ . Constitutively active Notch4 promotes early human hematopoietic progenitor cell maintenance while inhibiting differentiation and causes lymphoid abnormalities in vivo. Blood 2004; 104: 2315\u20132322.","journal-title":"Blood"},{"key":"BFleu2009223_CR42","doi-asserted-by":"crossref","first-page":"965","DOI":"10.4161\/cc.7.8.5753","volume":"7","author":"T Palomero","year":"2008","unstructured":"Palomero T, Dominguez M, Ferrando AA . The role of the PTEN\/AKT Pathway in NOTCH1-induced leukemia. Cell Cycle 2008; 7: 965\u2013970.","journal-title":"Cell Cycle"},{"key":"BFleu2009223_CR43","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.1182\/blood-2008-02-136762","volume":"113","author":"K Cullion","year":"2009","unstructured":"Cullion K, Draheim KM, Hermance N, Tammam J, Sharma VM, Ware C et al. Targeting the Notch1 and mTOR pathways in a mouse T-ALL model. Blood 2009; 113: 6172\u20136181.","journal-title":"Blood"},{"key":"BFleu2009223_CR44","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1182\/blood-2008-03-147967","volume":"113","author":"I Joshi","year":"2009","unstructured":"Joshi I, Minter LM, Telfer J, Demarest RM, Capobianco AJ, Aster JC et al. Notch signaling mediates G1\/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases. Blood 2009; 113: 1689\u20131698.","journal-title":"Blood"},{"key":"BFleu2009223_CR45","doi-asserted-by":"crossref","first-page":"20059","DOI":"10.1074\/jbc.R700016200","volume":"282","author":"C Schindler","year":"2007","unstructured":"Schindler C, Levy DE, Decker T . JAK-STAT signaling: from interferons to cytokines. J Biol Chem 2007; 282: 20059\u201320063.","journal-title":"J Biol Chem"},{"key":"BFleu2009223_CR46","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.tibs.2007.12.002","volume":"33","author":"SN Constantinescu","year":"2008","unstructured":"Constantinescu SN, Girardot M, Pecquet C . Mining for JAK-STAT mutations in cancer. Trends Biochem Sci 2008; 33: 122\u2013131.","journal-title":"Trends Biochem Sci"},{"key":"BFleu2009223_CR47","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.semcdb.2008.07.011","volume":"19","author":"L Wei","year":"2008","unstructured":"Wei L, Laurence A, O\u2019Shea JJ . New insights into the roles of Stat5a\/b and Stat3 in T-cell development and differentiation. Semin Cell Dev Biol 2008; 19: 394\u2013400.","journal-title":"Semin Cell Dev Biol"},{"key":"BFleu2009223_CR48","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.278.5341.1309","volume":"278","author":"V Lacronique","year":"1997","unstructured":"Lacronique V, Boureux A, Valle VD, Poirel H, Quang CT, Mauchauffe M et al. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. Science 1997; 278: 1309\u20131312.","journal-title":"Science"},{"key":"BFleu2009223_CR49","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1093\/emboj\/17.18.5321","volume":"17","author":"J Schwaller","year":"1998","unstructured":"Schwaller J, Frantsve J, Aster J, Williams IR, Tomasson MH, Ross TS et al. Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL\/JAK2 fusion genes. EMBO J 1998; 17: 5321\u20135333.","journal-title":"EMBO J"},{"key":"BFleu2009223_CR50","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1084\/jem.20072182","volume":"205","author":"E Flex","year":"2008","unstructured":"Flex E, Petrangeli V, Stella L, Chiaretti S, Hornakova T, Knoops L et al. Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia. J Exp Med 2008; 205: 751\u2013758.","journal-title":"J Exp Med"},{"key":"BFleu2009223_CR51","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/sj.leu.2404104","volume":"20","author":"J Adelaide","year":"2006","unstructured":"Adelaide J, Perot C, Gelsi-Boyer V, Pautas C, Murati A, Copie-Bergman C et al. A t(8;9) translocation with PCM1-JAK2 fusion in a patient with T-cell lymphoma. Leukemia 2006; 20: 536\u2013537.","journal-title":"Leukemia"},{"key":"BFleu2009223_CR52","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/modpathol.2008.207","volume":"22","author":"C Meier","year":"2009","unstructured":"Meier C, Hoeller S, Bourgau C, Hirschmann P, Schwaller J, Went P et al. Recurrent numerical aberrations of JAK2 and deregulation of the JAK2-STAT cascade in lymphomas. Mod Pathol 2009; 22: 476\u2013487.","journal-title":"Mod Pathol"},{"key":"BFleu2009223_CR53","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/sj.onc.1209178","volume":"25","author":"B Ballester","year":"2006","unstructured":"Ballester B, Ramuz O, Gisselbrecht C, Doucet G, Loi L, Loriod B et al. Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas. Oncogene 2006; 25: 1560\u20131570.","journal-title":"Oncogene"},{"key":"BFleu2009223_CR54","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0301-472X(03)00007-9","volume":"31","author":"H Ruchatz","year":"2003","unstructured":"Ruchatz H, Coluccia AM, Stano P, Marchesi E, Gambacorti-Passerini C . Constitutive activation of Jak2 contributes to proliferation and resistance to apoptosis in NPM\/ALK-transformed cells. Exp Hematol 2003; 31: 309\u2013315.","journal-title":"Exp Hematol"},{"key":"BFleu2009223_CR55","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/sj.onc.1205152","volume":"21","author":"A Zamo","year":"2002","unstructured":"Zamo A, Chiarle R, Piva R, Howes J, Fan Y, Chilosi M et al. Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death. Oncogene 2002; 21: 1038\u20131047.","journal-title":"Oncogene"},{"key":"BFleu2009223_CR56","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.4049\/jimmunol.165.9.5097","volume":"165","author":"RA Kirken","year":"2000","unstructured":"Kirken RA, Erwin RA, Wang L, Wang Y, Rui H, Farrar WL . Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T-cell leukemia virus type 1-transformed human T cells. J Immunol 2000; 165: 5097\u20135104.","journal-title":"J Immunol"},{"key":"BFleu2009223_CR57","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.4161\/cc.5.22.3449","volume":"5","author":"AE Schade","year":"2006","unstructured":"Schade AE, Wlodarski MW, Maciejewski JP . Pathophysiology defined by altered signal transduction pathways: the role of JAK-STAT and PI3 K signaling in leukemic large granular lymphocytes. Cell Cycle 2006; 5: 2571\u20132574.","journal-title":"Cell Cycle"},{"key":"BFleu2009223_CR58","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/sj.leu.2403385","volume":"18","author":"VH Sommer","year":"2004","unstructured":"Sommer VH, Clemmensen OJ, Nielsen O, Wasik M, Lovato P, Brender C et al. In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3. Leukemia 2004; 18: 1288\u20131295.","journal-title":"Leukemia"},{"key":"BFleu2009223_CR59","first-page":"9048","volume":"63","author":"TJ Mitchell","year":"2003","unstructured":"Mitchell TJ, Whittaker SJ, John S . Dysregulated expression of COOH-terminally truncated Stat5 and loss of IL2-inducible Stat5-dependent gene expression in Sezary syndrome. Cancer Res 2003; 63: 9048\u20139054.","journal-title":"Cancer Res"},{"key":"BFleu2009223_CR60","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1038\/labinvest.3700348","volume":"85","author":"M Marzec","year":"2005","unstructured":"Marzec M, Kasprzycka M, Ptasznik A, Wlodarski P, Zhang Q, Odum N et al. Inhibition of ALK enzymatic activity in T-cell lymphoma cells induces apoptosis and suppresses proliferation and STAT3 phosphorylation independently of Jak3. Lab Invest 2005; 85: 1544\u20131554.","journal-title":"Lab Invest"},{"key":"BFleu2009223_CR61","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.4049\/jimmunol.162.7.3897","volume":"162","author":"LH Wang","year":"1999","unstructured":"Wang LH, Kirken RA, Erwin RA, Yu CR, Farrar WL . JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T-cell response. J Immunol 1999; 162: 3897\u20133904.","journal-title":"J Immunol"},{"key":"BFleu2009223_CR62","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1172\/JCI9940","volume":"107","author":"PK Epling-Burnette","year":"2001","unstructured":"Epling-Burnette PK, Liu JH, Catlett-Falcone R, Turkson J, Oshiro M, Kothapalli R et al. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest 2001; 107: 351\u2013362.","journal-title":"J Clin Invest"},{"key":"BFleu2009223_CR63","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/sj.leu.2402093","volume":"15","author":"KW Eriksen","year":"2001","unstructured":"Eriksen KW, Kaltoft K, Mikkelsen G, Nielsen M, Zhang Q, Geisler C et al. Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells. Leukemia 2001; 15: 787\u2013793.","journal-title":"Leukemia"},{"key":"BFleu2009223_CR64","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.bbrc.2005.12.014","volume":"340","author":"J Rajasingh","year":"2006","unstructured":"Rajasingh J, Raikwar HP, Muthian G, Johnson C, Bright JJ . Curcumin induces growth-arrest and apoptosis in association with the inhibition of constitutively active JAK-STAT pathway in T-cell leukemia. Biochem Biophys Res Commun 2006; 340: 359\u2013368.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFleu2009223_CR65","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/sj.jid.5701246","volume":"128","author":"MS van Kester","year":"2008","unstructured":"van Kester MS, Out-Luiting JJ, von dem Borne PA, Willemze R, Tensen CP, Vermeer MH . Cucurbitacin I inhibits Stat3 and induces apoptosis in Sezary cells. J Invest Dermatol 2008; 128: 1691\u20131695.","journal-title":"J Invest Dermatol"},{"key":"BFleu2009223_CR66","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1038\/jid.2008.138","volume":"128","author":"C Zhang","year":"2008","unstructured":"Zhang C, Li B, Gaikwad AS, Haridas V, Xu Z, Gutterman JU et al. Avicin D selectively induces apoptosis and downregulates p-STAT-3, bcl-2, and survivin in cutaneous T-cell lymphoma cells. J Invest Dermatol 2008; 128: 2728\u20132735.","journal-title":"J Invest Dermatol"},{"key":"BFleu2009223_CR67","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1158\/0008-5472.CAN-07-6091","volume":"68","author":"VR Fantin","year":"2008","unstructured":"Fantin VR, Loboda A, Paweletz CP, Hendrickson RC, Pierce JW, Roth JA et al. Constitutive activation of signal transducers and activators of transcription predicts vorinostat resistance in cutaneous T-cell lymphoma. Cancer Res 2008; 68: 3785\u20133794.","journal-title":"Cancer Res"},{"key":"BFleu2009223_CR68","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrc780","volume":"2","author":"M Karin","year":"2002","unstructured":"Karin M, Cao Y, Greten FR, Li ZW . NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002; 2: 301\u2013310.","journal-title":"Nat Rev Cancer"},{"key":"BFleu2009223_CR69","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.4049\/jimmunol.154.7.3213","volume":"154","author":"J Sen","year":"1995","unstructured":"Sen J, Venkataraman L, Shinkai Y, Pierce JW, Alt FW, Burakoff SJ et al. Expression and induction of nuclear factor-kappa B-related proteins in thymocytes. J Immunol 1995; 154: 3213\u20133221.","journal-title":"J Immunol"},{"key":"BFleu2009223_CR70","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.4049\/jimmunol.167.10.5628","volume":"167","author":"AL Mora","year":"2001","unstructured":"Mora AL, Stanley S, Armistead W, Chan AC, Boothby M . Inefficient ZAP-70 phosphorylation and decreased thymic selection in vivo result from inhibition of NF-kappaB\/Rel. J Immunol 2001; 167: 5628\u20135635.","journal-title":"J Immunol"},{"key":"BFleu2009223_CR71","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1073\/pnas.0400885101","volume":"101","author":"M Schmidt-Supprian","year":"2004","unstructured":"Schmidt-Supprian M, Tian J, Grant EP, Pasparakis M, Maehr R, Ovaa H et al. Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-kappaB activation. Proc Natl Acad Sci USA 2004; 101: 4566\u20134571.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2009223_CR72","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/sj.leu.2401705","volume":"14","author":"U Kordes","year":"2000","unstructured":"Kordes U, Krappmann D, Heissmeyer V, Ludwig WD, Scheidereit C . Transcription factor NF-kappaB is constitutively activated in acute lymphoblastic leukemia cells. Leukemia 2000; 14: 399\u2013402.","journal-title":"Leukemia"},{"key":"BFleu2009223_CR73","doi-asserted-by":"crossref","first-page":"e2555","DOI":"10.1371\/journal.pone.0002555","volume":"3","author":"NR dos Santos","year":"2008","unstructured":"dos Santos NR, Williame M, Gachet S, Cormier F, Janin A, Weih D et al. RelB-dependent stromal cells promote T-cell leukemogenesis. PLoS ONE 2008; 3: e2555.","journal-title":"PLoS ONE"},{"key":"BFleu2009223_CR74","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/S0301-472X(99)00053-3","volume":"27","author":"N Arima","year":"1999","unstructured":"Arima N, Matsushita K, Obata H, Ohtsubo H, Fujiwara H, Arimura K et al. NF-kappaB involvement in the activation of primary adult T-cell leukemia cells and its clinical implications. Exp Hematol 1999; 27: 1168\u20131175.","journal-title":"Exp Hematol"},{"key":"BFleu2009223_CR75","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.febslet.2007.01.020","volume":"581","author":"JH Kim","year":"2007","unstructured":"Kim JH, Kim WS, Kang JH, Lim HY, Ko YH, Park C . Egr-1, a new downstream molecule of Epstein-Barr virus latent membrane protein 1. FEBS Lett 2007; 581: 623\u2013628.","journal-title":"FEBS Lett"},{"key":"BFleu2009223_CR76","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1200\/JCO.2007.11.4207","volume":"25","author":"PL Zinzani","year":"2007","unstructured":"Zinzani PL, Musuraca G, Tani M, Stefoni V, Marchi E, Fina M et al. Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma. J Clin Oncol 2007; 25: 4293\u20134297.","journal-title":"J Clin Oncol"},{"key":"BFleu2009223_CR77","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/sj.onc.1208212","volume":"24","author":"R Nasr","year":"2005","unstructured":"Nasr R, El-Sabban ME, Karam JA, Dbaibo G, Kfoury Y, Arnulf B et al. Efficacy and mechanism of action of the proteasome inhibitor PS-341 in T-cell lymphomas and HTLV-I associated adult T-cell leukemia\/lymphoma. Oncogene 2005; 24: 419\u2013430.","journal-title":"Oncogene"},{"key":"BFleu2009223_CR78","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1093\/annonc\/mdn431","volume":"19","author":"J Lee","year":"2008","unstructured":"Lee J, Suh C, Kang HJ, Ryoo BY, Huh J, Ko YH et al. Phase I study of proteasome inhibitor bortezomib plus CHOP in patients with advanced, aggressive T-cell or NK\/T-cell lymphoma. Ann Oncol 2008; 19: 2079\u20132083.","journal-title":"Ann Oncol"},{"key":"BFleu2009223_CR79","doi-asserted-by":"crossref","first-page":"600","DOI":"10.4161\/auto.4761","volume":"3","author":"P Yan","year":"2007","unstructured":"Yan P, Qing G, Qu Z, Wu CC, Rabson A, Xiao G . Targeting autophagic regulation of NF-kappaB in HTLV-I transformed cells by geldanamycin: implications for therapeutic interventions. Autophagy 2007; 3: 600\u2013603.","journal-title":"Autophagy"},{"key":"BFleu2009223_CR80","doi-asserted-by":"crossref","first-page":"24625","DOI":"10.1074\/jbc.M112063200","volume":"277","author":"A Ariga","year":"2002","unstructured":"Ariga A, Namekawa J, Matsumoto N, Inoue J, Umezawa K . Inhibition of tumor necrosis factor-alpha -induced nuclear translocation and activation of NF-kappa B by dehydroxymethylepoxyquinomicin. J Biol Chem 2002; 277: 24625\u201324630.","journal-title":"J Biol Chem"},{"key":"BFleu2009223_CR81","first-page":"1373","volume":"23","author":"J Gohda","year":"2003","unstructured":"Gohda J, Inoue J, Umezawa K . Down-regulation of TNF-alpha receptors by conophylline in human T-cell leukemia cells. Int J Oncol 2003; 23: 1373\u20131379.","journal-title":"Int J Oncol"},{"key":"BFleu2009223_CR82","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4161\/cc.7.3.5357","volume":"7","author":"H Medyouf","year":"2008","unstructured":"Medyouf H, Ghysdael J . The calcineurin\/NFAT signaling pathway: a novel therapeutic target in leukemia and solid tumors. Cell Cycle 2008; 7: 297\u2013303.","journal-title":"Cell Cycle"},{"key":"BFleu2009223_CR83","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1074-7613(04)00052-4","volume":"20","author":"JR Neilson","year":"2004","unstructured":"Neilson JR, Winslow MM, Hur EM, Crabtree GR . Calcineurin B1 is essential for positive but not negative selection during thymocyte development. Immunity 2004; 20: 255\u2013266.","journal-title":"Immunity"},{"key":"BFleu2009223_CR84","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2141.2004.05313.x","volume":"128","author":"T Marafioti","year":"2005","unstructured":"Marafioti T, Pozzobon M, Hansmann ML, Ventura R, Pileri SA, Roberton H et al. The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas. Br J Haematol 2005; 128: 333\u2013342.","journal-title":"Br J Haematol"},{"key":"BFleu2009223_CR85","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nm1588","volume":"13","author":"H Medyouf","year":"2007","unstructured":"Medyouf H, Alcalde H, Berthier C, Guillemin MC, dos Santos NR, Janin A et al. Targeting calcineurin activation as a therapeutic strategy for T-cell acute lymphoblastic leukemia. Nat Med 2007; 13: 736\u2013741.","journal-title":"Nat Med"},{"key":"BFleu2009223_CR86","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1182\/blood-2005-02-0493","volume":"106","author":"SZ Glud","year":"2005","unstructured":"Glud SZ, Sorensen AB, Andrulis M, Wang B, Kondo E, Jessen R et al. A tumor-suppressor function for NFATc3 in T-cell lymphomagenesis by murine leukemia virus. Blood 2005; 106: 3546\u20133552.","journal-title":"Blood"},{"key":"BFleu2009223_CR87","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00007890-199801150-00005","volume":"65","author":"FJ Dumont","year":"1998","unstructured":"Dumont FJ, Koprak S, Staruch MJ, Talento A, Koo G, DaSilva C et al. A tacrolimus-related immunosuppressant with reduced toxicity. Transplantation 1998; 65: 18\u201326.","journal-title":"Transplantation"},{"key":"BFleu2009223_CR88","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S1053-2498(03)00033-0","volume":"22","author":"M Stalder","year":"2003","unstructured":"Stalder M, Birsan T, Hubble RW, Paniagua RT, Morris RE . In vivo evaluation of the novel calcineurin inhibitor ISATX247 in non-human primates. J Heart Lung Transplant 2003; 22: 1343\u20131352.","journal-title":"J Heart Lung Transplant"},{"key":"BFleu2009223_CR89","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1128\/MCB.19.4.2435","volume":"19","author":"HJ Schaeffer","year":"1999","unstructured":"Schaeffer HJ, Weber MJ . Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol 1999; 19: 2435\u20132444.","journal-title":"Mol Cell Biol"},{"key":"BFleu2009223_CR90","doi-asserted-by":"crossref","first-page":"13574","DOI":"10.1073\/pnas.0505110102","volume":"102","author":"LK McNeil","year":"2005","unstructured":"McNeil LK, Starr TK, Hogquist KA . A requirement for sustained ERK signaling during thymocyte positive selection in vivo. Proc Natl Acad Sci USA 2005; 102: 13574\u201313579.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2009223_CR91","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1074-7613(00)80639-1","volume":"9","author":"T Sugawara","year":"1998","unstructured":"Sugawara T, Moriguchi T, Nishida E, Takahama Y . Differential roles of ERK and p38 MAP kinase pathways in positive and negative selection of T lymphocytes. Immunity 1998; 9: 565\u2013574.","journal-title":"Immunity"},{"key":"BFleu2009223_CR92","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1084\/jem.193.3.317","volume":"193","author":"K Sabapathy","year":"2001","unstructured":"Sabapathy K, Kallunki T, David JP, Graef I, Karin M, Wagner EF . c-Jun NH2-terminal kinase (JNK)1 and JNK2 have similar and stage-dependent roles in regulating T-cell apoptosis and proliferation. J Exp Med 2001; 193: 317\u2013328.","journal-title":"J Exp Med"},{"key":"BFleu2009223_CR93","first-page":"801","volume":"13","author":"JT Cheng","year":"1993","unstructured":"Cheng JT, Cobb MH, Baer R . Phosphorylation of the TAL1 oncoprotein by the extracellular-signal-regulated protein kinase ERK1. Mol Cell Biol 1993; 13: 801\u2013808.","journal-title":"Mol Cell Biol"},{"key":"BFleu2009223_CR94","first-page":"3713","volume":"9","author":"IA Wadman","year":"1994","unstructured":"Wadman IA, Hsu HL, Cobb MH, Baer R . The MAP kinase phosphorylation site of TAL1 occurs within a transcriptional activation domain. Oncogene 1994; 9: 3713\u20133716.","journal-title":"Oncogene"},{"key":"BFleu2009223_CR95","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/carcin\/bgm294","volume":"29","author":"KT Leung","year":"2008","unstructured":"Leung KT, Li KK, Sun SS, Chan PK, Ooi VE, Chiu LC . Activation of the JNK pathway promotes phosphorylation and degradation of BimEL--a novel mechanism of chemoresistance in T-cell acute lymphoblastic leukemia. Carcinogenesis 2008; 29: 544\u2013551.","journal-title":"Carcinogenesis"},{"key":"BFleu2009223_CR96","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1182\/blood-2006-11-059451","volume":"110","author":"V Leventaki","year":"2007","unstructured":"Leventaki V, Drakos E, Medeiros LJ, Lim MS, Elenitoba-Johnson KS, Claret FX et al. NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK\/cJun signaling in anaplastic large-cell lymphoma. Blood 2007; 110: 1621\u20131630.","journal-title":"Blood"},{"key":"BFleu2009223_CR97","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1600-0560.2007.00924.x","volume":"35","author":"X Mao","year":"2008","unstructured":"Mao X, Orchard G, Mitchell TJ, Oyama N, Russell-Jones R, Vermeer MH et al. A genomic and expression study of AP-1 in primary cutaneous T-cell lymphoma: evidence for dysregulated expression of JUNB and JUND in MF and SS. J Cutan Pathol 2008; 35: 899\u2013910.","journal-title":"J Cutan Pathol"},{"key":"BFleu2009223_CR98","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/sj.leu.2404350","volume":"20","author":"T Krejsgaard","year":"2006","unstructured":"Krejsgaard T, Vetter-Kauczok CS, Woetmann A, Lovato P, Labuda T, Eriksen KW et al. Jak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphoma. Leukemia 2006; 20: 1759\u20131766.","journal-title":"Leukemia"},{"key":"BFleu2009223_CR99","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1016\/j.febslet.2006.05.031","volume":"580","author":"J Lu","year":"2006","unstructured":"Lu J, Quearry B, Harada H . p38-MAP kinase activation followed by BIM induction is essential for glucocorticoid-induced apoptosis in lymphoblastic leukemia cells. FEBS Lett 2006; 580: 3539\u20133544.","journal-title":"FEBS Lett"},{"key":"BFleu2009223_CR100","first-page":"1325","volume":"32","author":"DM Conrad","year":"2008","unstructured":"Conrad DM, Robichaud MR, Mader JS, Boudreau RT, Richardson AM, Giacomantonio CA et al. 2-Chloro-2\u2032-deoxyadenosine-induced apoptosis in T leukemia cells is mediated via a caspase-3-dependent mitochondrial feedback amplification loop. Int J Oncol 2008; 32: 1325\u20131333.","journal-title":"Int J Oncol"},{"key":"BFleu2009223_CR101","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1158\/0008-5472.CAN-04-3903","volume":"65","author":"P Turella","year":"2005","unstructured":"Turella P, Cerella C, Filomeni G, Bullo A, De Maria F, Ghibelli L et al. Proapoptotic activity of new glutathione S-transferase inhibitors. Cancer Res 2005; 65: 3751\u20133761.","journal-title":"Cancer Res"},{"key":"BFleu2009223_CR102","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1038\/sj.leu.2403929","volume":"19","author":"W Zhang","year":"2005","unstructured":"Zhang W, McQueen T, Schober W, Rassidakis G, Andreeff M, Konopleva M . Leukotriene B4 receptor inhibitor LY293111 induces cell cycle arrest and apoptosis in human anaplastic large-cell lymphoma cells via JNK phosphorylation. Leukemia 2005; 19: 1977\u20131984.","journal-title":"Leukemia"},{"key":"BFleu2009223_CR103","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/jcb.20134","volume":"93","author":"H Tsuboi","year":"2004","unstructured":"Tsuboi H, Hossain K, Akhand AA, Takeda K, Du J, Rifa\u2019i M et al. Paeoniflorin induces apoptosis of lymphocytes through a redox-linked mechanism. J Cell Biochem 2004; 93: 162\u2013172.","journal-title":"J Cell Biochem"},{"key":"BFleu2009223_CR104","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1158\/0008-5472.CAN-03-2296","volume":"64","author":"N Miyoshi","year":"2004","unstructured":"Miyoshi N, Uchida K, Osawa T, Nakamura Y . A link between benzyl isothiocyanate-induced cell cycle arrest and apoptosis: involvement of mitogen-activated protein kinases in the Bcl-2 phosphorylation. Cancer Res 2004; 64: 2134\u20132142.","journal-title":"Cancer Res"},{"key":"BFleu2009223_CR105","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1158\/1541-7786.MCR-08-0342","volume":"7","author":"M Yoeli-Lerner","year":"2009","unstructured":"Yoeli-Lerner M, Chin YR, Hansen CK, Toker A . Akt\/protein kinase b and glycogen synthase kinase-3beta signaling pathway regulates cell migration through the NFAT1 transcription factor. Mol Cancer Res 2009; 7: 425\u2013432.","journal-title":"Mol Cancer Res"},{"key":"BFleu2009223_CR106","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/nm1524","volume":"13","author":"T Vilimas","year":"2007","unstructured":"Vilimas T, Mascarenhas J, Palomero T, Mandal M, Buonamici S, Meng F et al. Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia. Nat Med 2007; 13: 70\u201377.","journal-title":"Nat Med"},{"key":"BFleu2009223_CR107","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/sj.onc.1208302","volume":"24","author":"MP Felli","year":"2005","unstructured":"Felli MP, Vacca A, Calce A, Bellavia D, Campese AF, Grillo R et al. PKC theta mediates pre-TCR signaling and contributes to Notch3-induced T-cell leukemia. Oncogene 2005; 24: 992\u20131000.","journal-title":"Oncogene"},{"key":"BFleu2009223_CR108","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/ncb1138","volume":"6","author":"S Kamakura","year":"2004","unstructured":"Kamakura S, Oishi K, Yoshimatsu T, Nakafuku M, Masuyama N, Gotoh Y . Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signalling. Nat Cell Biol 2004; 6: 547\u2013554.","journal-title":"Nat Cell Biol"},{"key":"BFleu2009223_CR109","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.devcel.2005.02.016","volume":"8","author":"C Mammucari","year":"2005","unstructured":"Mammucari C, Tommasi di Vignano A, Sharov AA, Neilson J, Havrda MC, Roop DR et al. Integration of Notch 1 and calcineurin\/NFAT signaling pathways in keratinocyte growth and differentiation control. Dev Cell 2005; 8: 665\u2013676.","journal-title":"Dev Cell"},{"key":"BFleu2009223_CR110","doi-asserted-by":"crossref","first-page":"14308","DOI":"10.1073\/pnas.0501600102","volume":"102","author":"JW Kim","year":"2005","unstructured":"Kim JW, Kim MJ, Kim KJ, Yun HJ, Chae JS, Hwang SG et al. Notch interferes with the scaffold function of JNK-interacting protein 1 to inhibit the JNK signaling pathway. Proc Natl Acad Sci USA 2005; 102: 14308\u201314313.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2009223_CR111","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1161\/CIRCULATIONAHA.105.561522","volume":"112","author":"YT Xuan","year":"2005","unstructured":"Xuan YT, Guo Y, Zhu Y, Wang OL, Rokosh G, Messing RO et al. Role of the protein kinase C-epsilon-Raf-1-MEK-1\/2-p44\/42 MAPK signaling cascade in the activation of signal transducers and activators of transcription 1 and 3 and induction of cyclooxygenase-2 after ischemic preconditioning. Circulation 2005; 112: 1971\u20131978.","journal-title":"Circulation"},{"key":"BFleu2009223_CR112","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1210\/mend.13.4.0263","volume":"13","author":"TJ Pircher","year":"1999","unstructured":"Pircher TJ, Petersen H, Gustafsson JA, Haldosen LA . Extracellular signal-regulated kinase (ERK) interacts with signal transducer and activator of transcription (STAT) 5a. Mol Endocrinol 1999; 13: 555\u2013565.","journal-title":"Mol Endocrinol"},{"key":"BFleu2009223_CR113","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1128\/MCB.26.10.3785-3797.2006","volume":"26","author":"Q Liu","year":"2006","unstructured":"Liu Q, Wilkins BJ, Lee YJ, Ichijo H, Molkentin JD . Direct interaction and reciprocal regulation between ASK1 and calcineurin-NFAT control cardiomyocyte death and growth. Mol Cell Biol 2006; 26: 3785\u20133797.","journal-title":"Mol Cell Biol"},{"key":"BFleu2009223_CR114","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1158\/1535-7163.MCT-06-0235","volume":"5","author":"C Yu","year":"2006","unstructured":"Yu C, Friday BB, Lai JP, Yang L, Sarkaria J, Kay NE et al. Cytotoxic synergy between the multikinase inhibitor sorafenib and the proteasome inhibitor bortezomib in vitro: induction of apoptosis through Akt and c-Jun NH2-terminal kinase pathways. Mol Cancer Ther 2006; 5: 2378\u20132387.","journal-title":"Mol Cancer Ther"},{"key":"BFleu2009223_CR115","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/leu.2009.41","volume":"23","author":"QL Zhang","year":"2009","unstructured":"Zhang QL, Wang L, Zhang YW, Jiang XX, Yang F, Wu WL et al. The proteasome inhibitor bortezomib interacts synergistically with the histone deacetylase inhibitor suberoylanilide hydroxamic acid to induce T-leukemia\/lymphoma cells apoptosis. Leukemia 2009; 23: 1507\u20131514.","journal-title":"Leukemia"},{"key":"BFleu2009223_CR116","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.cellsig.2009.03.009","volume":"21","author":"FH Sarkar","year":"2009","unstructured":"Sarkar FH, Li Y, Wang Z, Kong D . Cellular signaling perturbation by natural products. Cell Signal 2009; 21: 1541\u20131547.","journal-title":"Cell Signal"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2009223.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2009223","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2009223.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T09:52:27Z","timestamp":1685181147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2009223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,29]]},"references-count":116,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["BFleu2009223"],"URL":"https:\/\/doi.org\/10.1038\/leu.2009.223","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,29]]},"assertion":[{"value":"28 June 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}